当前位置： SCI文献检索 > CORONARY ARTERY DISEASE期刊下所有文献 > Safety of ergot stress echocardiography for non-invasive detection of coronary vasospasm.

Safety of ergot stress echocardiography for non-invasive detection of coronary vasospasm.

Abstract：

BACKGROUND:The safety of ergonovine/ergometrine stress testing for coronary vasospasm when performed outside the cardiac catheterization laboratory (cath lab) has been questioned vigorously. AIM:To assess the tolerability and safety of ergonovine/ergometrine stress testing performed in the echocardiographic laboratory (echo lab). METHODS:We retrospectively reviewed the data prospectively collected in the echo lab of the Institute of Clinical Physiology from 1 January 1985 to 1 June 2000, from 587 tests performed on 573 patients (either ergonovine or ergometrine stress echocardiography testing). By selection, all patients had a history of chest pain, consistent with vasospastic angina, negative exercise stress testing or stress echocardiography (with dipyridamole, dobutamine or exercise), and normal or near normal resting left ventricular function. Ergonovine or ergometrine maleate was injected up to a total cumulative dosage of 0.35 mg, under continuous 12-lead electrocardiographic and two-dimensional echocardiographic monitoring. RESULTS:There were no deaths, myocardial infarctions, ventricular fibrillations or third degree AV blocks. One patient had non-sustained ventricular tachycardia associated with transient ST segment elevation 30 min after the test. Three patients had second degree AV block associated with a positive echocardiography test that was promptly reversed by nitrates administration. Transient regional myocardial dysfunction occurred in 79 patients (13%). Limiting ischaemia-independent side effects were present in 17 patients (3%): hypotension in one, arterial hypertension in five, non-sustained ventricular tachycardia in two and nausea or vomiting in ten. The test was well tolerated and echocardiograms were interpretable in 97% of the tests performed. CONCLUSION:Pharmacological stress echocardiography with either ergonovine or ergometrine is well tolerated and can be performed with relatively low risk in the echo lab in properly selected patients in whom coronary vasospasm is suspected.

journal_name

Coron Artery Dis

journal_title

Coronary artery disease

authors

Pálinkás A,Picano E,Rodriguez O,Diordjevic-Dikic A,Landi P,Varga A,Ghelarducci B

doi

10.1097/00019501-200112000-00008

subject

Has Abstract

pub_date

2001-12-01 00:00:00

pages

649-54

issue

eissn

0954-6928

issn

1473-5830

journal_volume

pub_type

杂志文章,评审

在线工具

Safety of ergot stress echocardiography for non-invasive detection of coronary vasospasm.